LONDON - Maxim Pharmaceuticals Inc. became the first to make an all-electronic submission in Europe last week, when it filed for Ceplene in combination with interleukin-2 for the treatment of advanced malignant melanoma. (BioWorld International)
LONDON - Maxim Pharmaceuticals Inc. became the first to make an all-electronic submission in Europe last week, when it filed for Ceplene in combination with interleukin-2 for the treatment of advanced malignant melanoma. (BioWorld International)
LONDON - Astex Technology Ltd. raised £23 million (US$38.9 million) through its acquisition of German genomics company MetaGen Pharmaceuticals GmbH with its £15 million cash, and by raising £8 million from existing investors. (BioWorld International)
LONDON - Astex Technology Ltd. raised £23 million (US$38.9 million) through its acquisition of German genomics company MetaGen Pharmaceuticals GmbH with its £15 million cash, and by raising £8 million from existing investors. (BioWorld International)
LONDON - Alizyme plc raised £11.5 million (US$19.5 million) in a placing of 6.8 million shares, giving it financial headroom as it negotiates deals for its three Phase III products, and allowing it to expand the commercial potential of its anti-obesity drug, ATL-962, by funding an additional Phase II trial in Type II diabetes. (BioWorld International)
